Albert David Limited (ALBERTDAVD.NS)
INR 790.6
(1.11%)
INR 790.6
(1.11%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 4.97 Billion INR | 17.62% |
| 2022 | 4.23 Billion INR | 5.1% |
| 2021 | 4.02 Billion INR | 18.0% |
| 2020 | 3.41 Billion INR | 6.62% |
| 2019 | 3.2 Billion INR | 8.4% |
| 2018 | 2.95 Billion INR | 2.15% |
| 2017 | 2.89 Billion INR | 17.34% |
| 2016 | 2.46 Billion INR | 10.1% |
| 2015 | 2.23 Billion INR | 15.71% |
| 2014 | 1.93 Billion INR | -2.3% |
| 2013 | 1.97 Billion INR | -5.53% |
| 2012 | 2.09 Billion INR | 3.33% |
| 2011 | 2.02 Billion INR | 21.91% |
| 2010 | 1.66 Billion INR | -10.06% |
| 2009 | 1.84 Billion INR | 14.63% |
| 2008 | 1.61 Billion INR | 7.84% |
| 2007 | 1.49 Billion INR | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | - INR | -100.0% |
| 2023 Q1 | - INR | -100.0% |
| 2023 Q2 | 4.54 Billion INR | 0.0% |
| 2023 Q4 | 4.97 Billion INR | 0.0% |
| 2023 FY | 4.97 Billion INR | 17.62% |
| 2023 Q3 | - INR | -100.0% |
| 2022 Q4 | 4.23 Billion INR | 0.0% |
| 2022 Q1 | - INR | -100.0% |
| 2022 FY | 4.23 Billion INR | 5.1% |
| 2022 Q2 | 4.14 Billion INR | 0.0% |
| 2022 Q3 | - INR | -100.0% |
| 2021 Q1 | - INR | -100.0% |
| 2021 Q2 | 3.91 Billion INR | 0.0% |
| 2021 Q4 | 4.02 Billion INR | 0.0% |
| 2021 Q3 | - INR | -100.0% |
| 2021 FY | 4.02 Billion INR | 18.0% |
| 2020 Q2 | 3.3 Billion INR | 0.0% |
| 2020 Q4 | 3.41 Billion INR | 0.0% |
| 2020 Q3 | - INR | -100.0% |
| 2020 FY | 3.41 Billion INR | 6.62% |
| 2019 Q2 | 3.24 Billion INR | 0.0% |
| 2019 FY | 3.2 Billion INR | 8.4% |
| 2019 Q4 | 3.2 Billion INR | 0.0% |
| 2019 Q3 | - INR | -100.0% |
| 2019 Q1 | - INR | -100.0% |
| 2018 Q3 | - INR | -100.0% |
| 2018 Q4 | 2.95 Billion INR | 0.0% |
| 2018 FY | 2.95 Billion INR | 2.15% |
| 2018 Q1 | - INR | -100.0% |
| 2018 Q2 | 2.82 Billion INR | 0.0% |
| 2017 Q1 | - INR | -100.0% |
| 2017 Q4 | 2.89 Billion INR | 0.0% |
| 2017 Q3 | - INR | -100.0% |
| 2017 FY | 2.89 Billion INR | 17.34% |
| 2017 Q2 | 2.7 Billion INR | 0.0% |
| 2016 Q3 | - INR | -100.0% |
| 2016 FY | 2.46 Billion INR | 10.1% |
| 2016 Q1 | - INR | -100.0% |
| 2016 Q4 | 2.46 Billion INR | 0.0% |
| 2016 Q2 | 2.37 Billion INR | 0.0% |
| 2015 Q3 | - INR | -100.0% |
| 2015 Q4 | 2.23 Billion INR | 0.0% |
| 2015 FY | 2.23 Billion INR | 15.71% |
| 2015 Q2 | 1.98 Billion INR | 0.0% |
| 2014 Q1 | - INR | -100.0% |
| 2014 Q3 | - INR | -100.0% |
| 2014 Q2 | 1.89 Billion INR | 0.0% |
| 2014 FY | 1.93 Billion INR | -2.3% |
| 2014 Q4 | 1.93 Billion INR | 0.0% |
| 2013 Q2 | 2.21 Billion INR | 0.0% |
| 2013 Q4 | 1.97 Billion INR | 0.0% |
| 2013 FY | 1.97 Billion INR | -5.53% |
| 2013 Q1 | - INR | -100.0% |
| 2013 Q3 | - INR | -100.0% |
| 2012 FY | 2.09 Billion INR | 3.33% |
| 2012 Q4 | 2.09 Billion INR | 0.0% |
| 2012 Q2 | 2.08 Billion INR | 0.0% |
| 2011 FY | 2.02 Billion INR | 21.91% |
| 2011 Q4 | 2.02 Billion INR | 0.0% |
| 2010 FY | 1.66 Billion INR | -10.06% |
| 2009 FY | 1.84 Billion INR | 14.63% |
| 2008 FY | 1.61 Billion INR | 7.84% |
| 2007 FY | 1.49 Billion INR | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Aarti Drugs Limited | 24.32 Billion INR | 79.526% |
| Alembic Limited | 23.28 Billion INR | 78.616% |
| Biofil Chemicals and Pharmaceuticals Limited | 470.82 Million INR | -957.695% |
| Hester Biosciences Limited | 6.62 Billion INR | 24.814% |
| Hikal Limited | 24.87 Billion INR | 79.977% |
| Ind-Swift Limited | 6.54 Billion INR | 23.909% |
| Kilitch Drugs (India) Limited | 2.4 Billion INR | -107.443% |
| Unichem Laboratories Limited | 31.69 Billion INR | 84.287% |
| Alembic Pharmaceuticals Limited | 64.45 Billion INR | 92.274% |
| Bafna Pharmaceuticals Limited | 1.47 Billion INR | -237.206% |
| Bajaj HealthCare Limited | 7.65 Billion INR | 34.914% |
| Brooks Laboratories Limited | 904.45 Million INR | -450.599% |
| Eris Lifesciences Limited | 70.48 Billion INR | 92.935% |
| Solara Active Pharma Sciences Limited | 23.46 Billion INR | 78.778% |
| Jagsonpal Pharmaceuticals Limited | 2.17 Billion INR | -129.407% |
| Wanbury Limited | 3.43 Billion INR | -44.979% |
| Aarti Pharmalabs Limited | 25.82 Billion INR | 80.714% |
| Alkem Laboratories Limited | 155.74 Billion INR | 96.803% |
| FDC Limited | 24.68 Billion INR | 79.823% |
| Glenmark Life Sciences Limited | 28.5 Billion INR | 82.529% |
| Gufic Biosciences Limited | 10.92 Billion INR | 54.419% |
| Ind-Swift Laboratories Limited | 11.65 Billion INR | 57.258% |
| Innova Captab Limited | 13.2 Billion INR | 62.299% |
| IOL Chemicals and Pharmaceuticals Limited | 22.44 Billion INR | 77.812% |
| Ipca Laboratories Limited | 111.01 Billion INR | 95.514% |
| Jubilant Pharmova Limited | 115.48 Billion INR | 95.688% |
| Lincoln Pharmaceuticals Limited | 7 Billion INR | 28.888% |
| Lupin Limited | 239.97 Billion INR | 97.925% |
| Mangalam Drugs & Organics Limited | 3.33 Billion INR | -49.357% |
| Medico Remedies Limited | 961.95 Million INR | -417.688% |
| Morepen Laboratories Limited | 12.93 Billion INR | 61.492% |
| Nectar Lifesciences Limited | 21.91 Billion INR | 77.272% |
| Orchid Pharma Limited | 15.53 Billion INR | 67.952% |
| Procter & Gamble Health Limited | 7.94 Billion INR | 37.309% |
| RPG Life Sciences Limited | 5.12 Billion INR | 2.901% |
| Sigachi Industries Limited | 6.94 Billion INR | 28.259% |
| Sun Pharmaceutical Industries Limited | 854.62 Billion INR | 99.417% |
| Suven Pharmaceuticals Limited | 22.54 Billion INR | 77.907% |
| Themis Medicare Limited | 5.66 Billion INR | 12.08% |
| Vaishali Pharma Limited | 799.55 Million INR | -522.834% |
| Venus Remedies Limited | 6.26 Billion INR | 20.554% |
| Windlas Biotech Limited | 6.26 Billion INR | 20.475% |
| ZIM Laboratories Limited | 4.46 Billion INR | -11.452% |
| Sakar Healthcare Limited | 3.88 Billion INR | -28.131% |
| Aurobindo Pharma Limited | 450.71 Billion INR | 98.895% |
| Divi's Laboratories Limited | 154.7 Billion INR | 96.781% |
| AstraZeneca Pharma India Limited | 10.78 Billion INR | 53.805% |
| Mankind Pharma Limited | 119.63 Billion INR | 95.837% |
| Sequent Scientific Limited | 15.4 Billion INR | 67.671% |
| Laurus Labs Limited | 83.87 Billion INR | 94.062% |
| Neuland Laboratories Limited | 18.32 Billion INR | 72.825% |
| J. B. Chemicals & Pharmaceuticals Limited | 39.94 Billion INR | 87.532% |
| Glenmark Pharmaceuticals Limited | 143.58 Billion INR | 96.532% |
| Zydus Lifesciences Limited | 292.8 Billion INR | 98.299% |
| Amrutanjan Health Care Limited | 3.66 Billion INR | -35.74% |
| Wockhardt Limited | 76.49 Billion INR | 93.489% |
| Bal Pharma Limited | 3.2 Billion INR | -55.433% |
| Dr. Reddy's Laboratories Limited | 387.51 Billion INR | 98.715% |
| Bliss GVS Pharma Limited | 12.13 Billion INR | 58.975% |
| Par Drugs and Chemicals Limited | 1.01 Billion INR | -390.096% |
| Caplin Point Laboratories Limited | 26.97 Billion INR | 81.538% |
| Shilpa Medicare Limited | 30.93 Billion INR | 83.9% |
| Valiant Laboratories Limited | 3.42 Billion INR | -45.32% |
| Ajanta Pharma Limited | 46.38 Billion INR | 89.264% |
| Aarey Drugs & Pharmaceuticals Limited | 3.04 Billion INR | -63.28% |
| Granules India Limited | 55.2 Billion INR | 90.98% |
| Medicamen Biotech Limited | 2.94 Billion INR | -69.084% |
| Syncom Formulations (India) Limited | 4.04 Billion INR | -23.063% |
| Piramal Enterprises Limited | 826.05 Billion INR | 99.397% |
| Torrent Pharmaceuticals Limited | 150.61 Billion INR | 96.694% |
| NATCO Pharma Limited | 69.06 Billion INR | 92.789% |
| Suven Life Sciences Limited | 2.84 Billion INR | -74.794% |
| Krebs Biochemicals & Industries Limited | 1.78 Billion INR | -179.496% |
| Strides Pharma Science Limited | 58.39 Billion INR | 91.472% |
| Indoco Remedies Limited | 21.44 Billion INR | 76.781% |
| Alpa Laboratories Limited | 1.82 Billion INR | -172.69% |
| Lasa Supergenerics Limited | 1.5 Billion INR | -230.083% |
| Sun Pharma Advanced Research Company Limited | 5.15 Billion INR | 3.31% |